News & Articles

FEATURED ARTICLE

Immunotherapy Target: CD19 Antigen

CD19 remains a hot target in immunotherapy, driving innovation across a range of diseases. This is evidenced by recent approvals for new treatments in multiple sclerosis and leukemia and a major acquisition in the bispecific antibody space...

Browse articles by topic:

Case Review: Exploring domain proteins in antibody development

January 22, 2025

7 min read

Domain Antigens for Antibody Discovery & Screening The antibody drug development underwent rapid progress over the past decade, with almost...

MRGPRX2: A Promising Target for Antibody Discovery in Allergy and Pain Disorders

October 28, 2024

5 min read

Recent studies have shown that various drugs, including small molecules, opioids, and antibiotics, can activate MRGPRX2 (Mas-related G-protein coupled receptor...

VLP Antibody Discover

October 2, 2024

4 min read

How VLPs are unlocking the next generation of antibody therapeutics for challenging transmembrane proteins Transmembrane proteins play crucial roles in...

Virus-Like Particles (VLPs): Understanding their Structure, Expression, and Role in Immune Response

August 28, 2024

7 min read

What are virus-like particles (VLPs)? Virus-like particles (VLPs) are nanoparticle structures (50-300nm diameter) that mimic the organization and conformation of...

TM4SF1 in Cancer Immunotherapy: Emerging Research and Clinical Potential

September 5, 2022

5 min read

TM4SF1 (Transmembrane 4L six family member 1) is a member of the TM4SF subfamily in the Tetraspanin superfamily. It was...

Have questions? Get in touch!

support@kactusbio.us